New compound offers hope for treating inflammatory bowel diseases

The findings of a recent study suggest that (S)-IBD3540 is a promising approach for treating IBD in people.

How a commensal microbe may boost the function of the skin barrier

The findings reveal an important mechanism through which commensal microbes influence skin’s health. The results may also help to inform treatments for people with skin conditions.

Gut microbiota is a key player for bone health in post-menopausal women

Bone resorption increases the risk of osteopenia and osteoporosis during and after menopause – learn about the importance of the gut microbiota to support healthy bones.

Alessio Fasano: ‘The future of personalized treatments and disease interception depends on microbiome research’

Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, talks about the mechanistic link between gut microbiome and disease pathogenesis and the impact on the future clinical practice.

Nestlé’s innovation: elevating infant nutrition with HMOs and probiotic synergy for science-based early-life health

Nestlé, a global leader in nutrition and wellness, is taking a giant leap forward in early-life nutrition with its latest innovation – Sinergity.

Lallemand Health Solutions Acquires Dietary Pros Inc., US-Based Contract Manufacturer

The acquisition brings together two complementary forces, continue to respond to customer needs and help their growth with their respective strengths.

Scientists advancing next generation probiotic development with synergy and oxygen adaptation

A recent study introduces a novel technique for developing next-generation probiotics, achieved by enabling strictly anaerobic bacteria to tolerate oxygen exposure without compromising their potential beneficial properties.

Nanoparticles in food may affect gut microbiome

This study highlights the potential risks associated with the use of nanoparticles in food production and processing.

Gianluca Ianiro: ‘Here’s why engraftment is a key determinant of success in FMT’

Gianluca Ianiro, from Gemelli Hospital in Rome, discusses the key determinants of success of FMT in the treatment of C. Difficile infections and other conditions.

Expert’biome CDMO by Lallemand: leading microbiome forward

Lallemand launches Expert’Biome™ CDMO to support partners in their development of next-generation strains.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top